Ragifilimab (INCAGN-1876) is an agonistic monoclonal antibody designed to specifically target the glucocorticoid-induced TNFR-related protein (GITR). This antibody has been developed for use in research involving advanced or metastatic solid tumors, exploring its potential to modulate immune responses and enhance anti-tumor activity. Ragifilimab provides a valuable tool for investigating the therapeutic implications of GITR activation in oncological studies.
Ragifilimab (INCAGN-1876) is an agonistic monoclonal antibody designed to specifically target the glucocorticoid-induced TNFR-related protein (GITR). This antibody has been developed for use in research involving advanced or metastatic solid tumors, exploring its potential to modulate immune responses and enhance anti-tumor activity. Ragifilimab provides a valuable tool for investigating the therapeutic implications of GITR activation in oncological studies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
